摘要:
Apparatus for treating a patient, comprising a sterile device for removing soluble receptors for tumor necrosis factor-1 (TNF-1), tumor necrosis factor-2 (TNF-2), interleukin-1 (IL-1), interleukin-2 (IL-2), interleukin-6 (IL-6) or interferon-gamma (IFN-γ) from blood or plasma of a patient, and having inlet and outlet means for connection to a pump and tubing to circulate the blood or plasma through the device. Preferably the device comprises antibodies or antibody fragments that selectively bind to the soluble receptors, or cytokines selected from TNF-1, TNF-2, IL-1, IL-2, IL-6 and IFN-γ or epitopes thereof that selectively bind to the respective soluble receptors, immobilized on a column or a filter.
摘要:
A method of generating and/or providing data (28) for tissue treatment, in particular a tumor treatment, via a low-energy irradiation appliance (10) is described. Herein, the low-energy irradiation appliance (10) has a radiation source (14) for generating soft radiation, preferably of a radiation with a spectrum from 0 to a maximal radiation energy of 100 keV, in particular a radiation with a spectrum from 0 to a maximal radiation energy of 50 keV and an emitting device (15) for emitting the radiation to tissue, which is to be irradiated. The method is characterized by the following steps: physical data of the radiation source (14) is determined directly from leaving the emitting device (15); quality data of the tissue, for example the tumor tissue and/or the tissue (17) in the vicinity of the tumor, is determined; physical property data of the determined tissue is determined in connection with the radiation of the radiation source (14). Data (28) for the tissue treatment, for example the tumor treatment, is generated from the determined data and/or the determined data is provided for generating data for the tissue treatment, in particular tumor treatment.
摘要:
Es werden unter anderem eine Applikatoreinrichtung (20) für die Röntgenstrahlentherapie zur Bestrahlung von Oberflächen, sowie eine Strahlentherapievorrichtung beschrieben, mit einem Applikatorelement (21) zur Aufnahme einer Sondeneinrichtung oder eines Strahlungsquellenelements einer Strahlungsquelleneinrichtung (11). Um die Applikatoreinrichtung (20) derart weiterzubilden, dass diese in besonderer Weise auch für die Bestrahlung von Oberflächen geeignet ist, ist vorgesehen, dass das Applikatorelement (21) zur Einstellung verschiedener Strahlcharakteristika wenigstens ein austauschbar am/im Applikatorelement (21) angeordnetes Element (27) zur Strahlbeeinflussung, insbesondere ein Linsenelement, aufweist. Weiterhin wird eine vorteilhafte Befestigungseinrichtung beschrieben, mittels derer die Applikatoreinrichtung (20) auf der zu behandelnden Oberfläche befestigt und fixiert werden kann.
摘要:
A method for preventing or treating atopic dermatitis of a patient by covering the patient itself or a patient's area affected by the atopic dermatitis, filling a covered space with positive ions composed of H + (H 2 O) m (m being any integer) and negative ions composed of O 2 - (H 2 O) n (n being any integer) generated as a result of discharge in an atmosphere, and bringing the positive ions and the negative ions into contact with a skin surface of the patient and a medical device for preventing or treating atopic dermatitis by covering a patient itself or an affected area, filling a covered space with positive ions composed of H + (H 2 O) m (m being any integer) and negative ions composed of O 2 - (H 2 O) n (n being any integer) generated as a result of discharge in an atmosphere, and bringing the positive ions and the negative ions into contact with a skin surface of the patient.
摘要:
Apparatus for treating a patient, comprising a sterile device for removing soluble receptors for tumor necrosis factor-1 (TNF-1), tumor necrosis factor-2 (TNF-2), interleukin-1 (IL-1), interleukin-2 (IL-2), interleukin-6 (IL-6) or interferon-gamma (IFN-³) from blood or plasma of a patient, and having inlet and outlet means for connection to a pump and tubing to circulate the blood or plasma through the device. Preferably the device comprises antibodies or antibody fragments that selectively bind to the soluble receptors, or cytokines selected from TNF-1, TNF-2, IL-1, IL-2, IL-6 and IFN-³ or epitopes thereof that selectively bind to the respective soluble receptors, immobilized on a column or a filter.
摘要:
A method of generating and/or providing data (28) for tissue treatment, in particular a tumor treatment, via a low-energy irradiation appliance (10) is described. Herein, the low-energy irradiation appliance (10) has a radiation source (14) for generating soft radiation, preferably of a radiation with a spectrum from 0 to a maximal radiation energy of 100 keV, in particular a radiation with a spectrum from 0 to a maximal radiation energy of 50 keV and an emitting device (15) for emitting the radiation to tissue, which is to be irradiated. The method is characterized by the following steps: physical data of the radiation source (14) is determined directly from leaving the emitting device (15); quality data of the tissue, for example the tumor tissue and/or the tissue (17) in the vicinity of the tumor, is determined; physical property data of the determined tissue is determined in connection with the radiation of the radiation source (14). Data (28) for the tissue treatment, for example the tumor treatment, is generated from the determined data and/or the determined data is provided for generating data for the tissue treatment, in particular tumor treatment.
摘要:
Es werden unter anderem eine Applikatoreinrichtung (20) für die Röntgenstrahlentherapie zur Bestrahlung von Oberflächen, sowie eine Strahlentherapievorrichtung beschrieben, mit einem Applikatorelement (21) zur Aufnahme einer Sondeneinrichtung oder eines Strahlungsquellenelements einer Strahlungsquelleneinrichtung (11). Um die Applikatoreinrichtung (20) derart weiterzubilden, dass diese in besonderer Weise auch für die Bestrahlung von Oberflächen geeignet ist, ist vorgesehen, dass das Applikatorelement (21) zur Einstellung verschiedener Strahlcharakteristika wenigstens ein austauschbar am/im Applikatorelement (21) angeordnetes Element (27) zur Strahlbeeinflussung, insbesondere ein Linsenelement, aufweist. Weiterhin wird eine vorteilhafte Befestigungseinrichtung beschrieben, mittels derer die Applikatoreinrichtung (20) auf der zu behandelnden Oberfläche befestigt und fixiert werden kann.
摘要:
Apparatus for treating a patient, comprising a sterile device for removing soluble receptors for tumor necrosis factor-1 (TNF-1), tumor necrosis factor-2 (TNF-2), interleukin-1 (IL-1), interleukin-2 (IL-2), interleukin-6 (IL-6) or interferon-gamma (IFN-γ) from blood or plasma of a patient, and having inlet and outlet means for connection to a pump and tubing to circulate the blood or plasma through the device. Preferably the device comprises antibodies or antibody fragments that selectively bind to the soluble receptors, or cytokines selected from TNF-1, TNF-2, IL-1, IL-2, IL-6 and IFN-γ or epitopes thereof that selectively bind to the respective soluble receptors, immobilized on a column or a filter.
摘要:
Apparatus for treating a patient, comprising a sterile device for removing soluble receptors for tumor necrosis factor-1 (TNF-1), tumor necrosis factor-2 (TNF-2), interleukin-1 (IL-1), interleukin-2 (IL-2), interleukin-6 (IL-6) or interferon-gamma (IFN-³) from blood or plasma of a patient, and having inlet and outlet means for connection to a pump and tubing to circulate the blood or plasma through the device. Preferably the device comprises antibodies or antibody fragments that selectively bind to the soluble receptors, or cytokines selected from TNF-1, TNF-2, IL-1, IL-2, IL-6 and IFN-³ or epitopes thereof that selectively bind to the respective soluble receptors, immobilized on a column or a filter.